AFP and hepatocellular carcinoma: To date, several promising serum tumor markers with the potential for early diagnosis and surveillance of HCC have been proposed [3,21,44,45,86,87,88,89,90,92,93] of which PIVKA II appears to be the most promising, with recently published data on its performance (alone or in combination with AFP or ultrasonography).